Metformin Zentiva

Metformin Hydrochloride, the active ingredient in Metformin Zentiva, is a biguanide presented as an oral tablet for oral use. It is used to lower elevated blood glucose levels in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Customers benefit from reliable logistics, temperature‑controlled shipping where required, and responsive technical support throughout the procurement process.

Metformin Zentiva, a biguanide antidiabetic, is employed in the management of glucose metabolism disorders.

Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.

Metformin Zentiva may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: loose stools, often transient. - Metallic taste: altered taste perception. - Weight loss: modest reduction in body weight.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: signs of liver injury including jaundice.

When prescribing Metformin Zentiva, clinicians should consider several safety considerations to minimize risk. - Renal function: assess baseline creatinine clearance and monitor periodically. - Hepatic disease: avoid use in patients with severe liver impairment. - Alcohol consumption: limit intake as it may increase risk of lactic acidosis. - Risk of lactic acidosis: educate patients to report unexplained fatigue, myalgia, or dyspnea. - Pregnancy and breastfeeding: evaluate benefits versus risks before use. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Metformin Zentiva can interact with other medicines, altering its plasma concentration or increasing adverse effect potential.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure, increasing lactic acidosis risk. - Cimetidine: can raise metformin plasma levels, heightening toxicity. - Rifampicin: may reduce metformin efficacy by increasing hepatic metabolism.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - ACE inhibitors or ARBs: monitor renal function and potassium when combined. - Thiazide diuretics: may affect glucose control and electrolyte balance.